Our agile research team has miles of experience.

We treat every project as a custom project.
Deep knowledge of pre-clinical technologies and methods.
Home 2018-01-14T18:14:56+00:00


Aragen’s RapTr™ Cell Line Development services combine the proven CHO-DG44 host cell line and vector combination with an innovative clone selection process that delivers high titers at every stage from Discovery to the Clinic.

Peptalk: The Protein Science Week
January 8-12, 2018 | San Diego, CA

Press Releases

Aragen Bioscience Announces AAALAC Accreditation

RapTr Cell Line Development Services Introduced